FAMILY HEALTH INTERNATIONAL
The Challenge TB project in Vietnam aimed to reduce tuberculosis (TB) and TB/HIV co-infection deaths by increasing access to timely and quality assured diagnosis and treatment of TB and multidrug-resistant (MDR) TB, particularly among vulnerable groups.
2016 · 43 pages

Abstract
The project was led by KNCV Tuberculosis Foundation in collaboration with the World Health Organization (WHO). The total budget for the second year was USD 757,522. Comprehensive high-quality diagnostic networks were established, with a focus on patient-centered care and treatment. TB infection control measures were implemented, and management of latent TB infection was prioritized. Political commitment and leadership were strengthened, and comprehensive partnerships and informed community involvement were fostered. Quality data, surveillance, and monitoring and evaluation (M&E) were also emphasized. The project supported 38.6 million people in 3,232 communes of 193 districts, equivalent to 39% of Vietnam's total population. Technical assistance and supervision were provided for the rollout of GeneXpert testing for key affected populations in PMDT provinces. The project also supported access to WHO-approved rapid diagnostic platforms in all 54 provinces within the framework of the PMDT of the National Tuberculosis Control Program. Key achievements included the establishment of a comprehensive high-quality diagnostic network, with a focus on patient-centered care and treatment. TB infection control measures were implemented, and management of latent TB infection was prioritized. The project also supported the rollout of GeneXpert testing for key affected populations in PMDT provinces. The project's geographic focus was on 15 provinces, including 4 HIV and TB high prevalence provinces, 9 MDR-TB treatment centers, and 2 PMDT satellite provinces. The project's implementation details involved technical assistance and supervision, as well as the provision of equipment and supplies. The project's timeframes were from October 1, 2015, to September 30, 2016. The project's recommendations included the continued support for access to WHO-approved rapid diagnostic platforms and the expansion of GeneXpert testing to additional provinces. The project's success was measured through the achievement of several outputs and outcomes, including the establishment of a comprehensive high-quality diagnostic network, the implementation of TB infection control measures, and the management of latent TB infection. The project also supported the rollout of GeneXpert testing for key affected populations in PMDT provinces.
Connected topics
Classification